Monopar Therapeutics Inc (MNPR)
Operating Income Growth
-105.44%
Quarterly · Period ending:
MNPR Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-105.44%period ending
Latest reported-105.44%period ending
MNPR Quarterly Operating Income YoY % (-10.98% → -105.44%)
Year-over-year change
High-resolution chart · PNG
MNPR operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -105.4439% | |
| -62.1834% | |
| 44.4205% | |
| -159.8939% | |
| -80.8097% | |
| -86.9464% | |
| -479.2214% | |
| 23.7703% | |
| 23.1691% | |
| 31.7481% | |
| 34.2733% | |
| 14.1796% | |
| 15.7468% | |
| -2.7616% | |
| -8.4994% | |
| 2.1014% | |
| -32.0663% | |
| -29.6863% | |
| -18.5942% | |
| -49.2143% | |
| -42.9103% | |
| -66.7862% | |
| -84.5668% | |
| -117.125% | |
| -57.0957% | |
| 19.2598% | |
| -22.735% | |
| -13.6228% | |
| -10.9524% | |
| -56.8562% | |
| -35.4138% | |
| 95.5162% | |
| -41.1765% | |
| -139.8396% | |
| -129.151% | |
| -7,467.6994% | |
| -76.5579% | |
| -10.9792% |